bacteriohopane-,32,33,34-triol-35-cyclitolguanine

2-[2-[(7S)-7-[(5aR,5bR,11aS,13bS)-5a,5b,8,8,11a,13b-hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-3-yl]-2,3,4-trihydroxyoctoxy]-3,4,5-trihydroxy-3-(hydroxymethyl)cyclopentyl]guanidine

HBYLSHNUNMUXCU-VCJINUIQSA-N CHEBI:188188 0 Reactome links 1 studies

Metabolite details

Identifier: HBYLSHNUNMUXCU-VCJINUIQSA-N
InChI Key: HBYLSHNUNMUXCU-VCJINUIQSA-N
IUPAC name: 2-[2-[(7S)-7-[(5aR,5bR,11aS,13bS)-5a,5b,8,8,11a,13b-hexamethyl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysen-3-yl]-2,3,4-trihydroxyoctoxy]-3,4,5-trihydroxy-3-(hydroxymethyl)cyclopentyl]guanidine
Preferred name: bacteriohopane-,32,33,34-triol-35-cyclitolguanine
INN name: —
Synonym: —
ChEBI: CHEBI:188188

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release

Observed in differential profiles

Control_16.6_months_vs_Treatment_16.6_months